跳至主要内容
临床试验/DRKS00034345
DRKS00034345尚未招募不适用

Multicenter MRI for Characterization Of Residual NeuroblasToma after Surgery - MULTICORNETS

niversitätsklinikum Tübingen0 个研究点开始时间: 2024年5月29日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 18 Years(—)
性别
All

入选标准

  • Clinical indication for MRI in preoperative MRI imaging before local therapy for high-risk/+IDRF neuroblastoma
  • or postoperative MRI imaging after local therapy of a high-risk/+IDRF neuroblastoma to evaluate a possible tumor residual
  • - Presence of all necessary laboratory parameters (creatinine/GFR without evidence of high-grade renal insufficiency; GFR >30 ml/min)
  • - Written consent to the study from the patient and/or legal guardian

排除标准

  • -Presence of implants that are not MR-compatible or any type of metal in or on the body (e.g. pacemakers, artificial heart valves, metal prostheses, implanted magnetic metal parts, etc. that are not MR-compatible)
  • - Non-compliance of the patient for an MRI examination and any study-related extension of the examination time.
  • - No written consent to the study from the patient and/or legal guardian

研究者

发起方
niversitätsklinikum Tübingen

相似试验